Successful Treatment with Mycophenolate Mofetil and Tacrolimus in Juvenile Severe Lupus Nephritis

Lupus nephritis (LN) of juvenile onset often has severe disease presentation. Despite aggressive induction therapy, up to 20% of patients with LN are resistant to initial therapy and up to 44% suffer a renal relapse. However, there is no consensus on an appropriate therapeutic regimen for refractory...

Full description

Saved in:
Bibliographic Details
Main Authors: Tomoo Kise, Hiroshi Yoshimura, Shigeru Fukuyama, Masatsugu Uehara
Format: Article
Language:English
Published: Wiley 2015-01-01
Series:Case Reports in Pediatrics
Online Access:http://dx.doi.org/10.1155/2015/651803
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832567510744956928
author Tomoo Kise
Hiroshi Yoshimura
Shigeru Fukuyama
Masatsugu Uehara
author_facet Tomoo Kise
Hiroshi Yoshimura
Shigeru Fukuyama
Masatsugu Uehara
author_sort Tomoo Kise
collection DOAJ
description Lupus nephritis (LN) of juvenile onset often has severe disease presentation. Despite aggressive induction therapy, up to 20% of patients with LN are resistant to initial therapy and up to 44% suffer a renal relapse. However, there is no consensus on an appropriate therapeutic regimen for refractory LN. We report a 13-year-old girl with recurrent LN who was not taking her medications. At age of 11 years, she was diagnosed with LN classified as International Society of Nephrology/Renal Pathology Society (ISN/RPS) class IV G (A) + V. She was treated with prednisolone and MMF after nine methylprednisolone pulses. Nineteen months later, she was admitted to the hospital with generalized edema. Her symptoms were nephrotic syndrome and acute renal dysfunction. She received three methylprednisolone pulses for 3 days, followed by oral prednisolone and MMF. Twenty-seven days after the three methylprednisolone pulses, her acute renal dysfunction was improved, but the nephrotic syndrome was not improved. A second biopsy showed diffuse lupus nephritis classified as the predominant finding of ISN/RPS class V. We added tacrolimus to the MMF. Four months after adding tacrolimus, the nephrotic syndrome improved. We conclude that adding tacrolimus to the treatment regimen for LN resistant to MMF is effective.
format Article
id doaj-art-4879e1e0c5654d03bc5e0fc5b635179a
institution Kabale University
issn 2090-6803
2090-6811
language English
publishDate 2015-01-01
publisher Wiley
record_format Article
series Case Reports in Pediatrics
spelling doaj-art-4879e1e0c5654d03bc5e0fc5b635179a2025-02-03T01:01:13ZengWileyCase Reports in Pediatrics2090-68032090-68112015-01-01201510.1155/2015/651803651803Successful Treatment with Mycophenolate Mofetil and Tacrolimus in Juvenile Severe Lupus NephritisTomoo Kise0Hiroshi Yoshimura1Shigeru Fukuyama2Masatsugu Uehara3Division of Pediatric Nephrology, Okinawa Prefectural Nanbu Medical Center-Children’s Medical Center, Arakawa 118-1, Haebaru, Okinawa 901-1193, JapanDivision of Pediatric Nephrology, Okinawa Prefectural Nanbu Medical Center-Children’s Medical Center, Arakawa 118-1, Haebaru, Okinawa 901-1193, JapanDivision of Pediatric Nephrology, Okinawa Prefectural Nanbu Medical Center-Children’s Medical Center, Arakawa 118-1, Haebaru, Okinawa 901-1193, JapanDivision of Pediatric Nephrology, Okinawa Prefectural Nanbu Medical Center-Children’s Medical Center, Arakawa 118-1, Haebaru, Okinawa 901-1193, JapanLupus nephritis (LN) of juvenile onset often has severe disease presentation. Despite aggressive induction therapy, up to 20% of patients with LN are resistant to initial therapy and up to 44% suffer a renal relapse. However, there is no consensus on an appropriate therapeutic regimen for refractory LN. We report a 13-year-old girl with recurrent LN who was not taking her medications. At age of 11 years, she was diagnosed with LN classified as International Society of Nephrology/Renal Pathology Society (ISN/RPS) class IV G (A) + V. She was treated with prednisolone and MMF after nine methylprednisolone pulses. Nineteen months later, she was admitted to the hospital with generalized edema. Her symptoms were nephrotic syndrome and acute renal dysfunction. She received three methylprednisolone pulses for 3 days, followed by oral prednisolone and MMF. Twenty-seven days after the three methylprednisolone pulses, her acute renal dysfunction was improved, but the nephrotic syndrome was not improved. A second biopsy showed diffuse lupus nephritis classified as the predominant finding of ISN/RPS class V. We added tacrolimus to the MMF. Four months after adding tacrolimus, the nephrotic syndrome improved. We conclude that adding tacrolimus to the treatment regimen for LN resistant to MMF is effective.http://dx.doi.org/10.1155/2015/651803
spellingShingle Tomoo Kise
Hiroshi Yoshimura
Shigeru Fukuyama
Masatsugu Uehara
Successful Treatment with Mycophenolate Mofetil and Tacrolimus in Juvenile Severe Lupus Nephritis
Case Reports in Pediatrics
title Successful Treatment with Mycophenolate Mofetil and Tacrolimus in Juvenile Severe Lupus Nephritis
title_full Successful Treatment with Mycophenolate Mofetil and Tacrolimus in Juvenile Severe Lupus Nephritis
title_fullStr Successful Treatment with Mycophenolate Mofetil and Tacrolimus in Juvenile Severe Lupus Nephritis
title_full_unstemmed Successful Treatment with Mycophenolate Mofetil and Tacrolimus in Juvenile Severe Lupus Nephritis
title_short Successful Treatment with Mycophenolate Mofetil and Tacrolimus in Juvenile Severe Lupus Nephritis
title_sort successful treatment with mycophenolate mofetil and tacrolimus in juvenile severe lupus nephritis
url http://dx.doi.org/10.1155/2015/651803
work_keys_str_mv AT tomookise successfultreatmentwithmycophenolatemofetilandtacrolimusinjuvenileseverelupusnephritis
AT hiroshiyoshimura successfultreatmentwithmycophenolatemofetilandtacrolimusinjuvenileseverelupusnephritis
AT shigerufukuyama successfultreatmentwithmycophenolatemofetilandtacrolimusinjuvenileseverelupusnephritis
AT masatsuguuehara successfultreatmentwithmycophenolatemofetilandtacrolimusinjuvenileseverelupusnephritis